Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials

Authors: Jacques Donnez, Hugh S. Taylor, Elizabeth A. Stewart, Linda Bradley, Erica E. Marsh, David F. Archer, Ayman Al‐Hendy, Felice Petraglia, Nelson B. Watts, Jean‐Pierre Gotteland, Elke Bestel, Paul Terrill, Ernest Loumaye, Andrew Humberstone, Elizabeth Garner - The Lancet 2022 cited by 72